Chapter 3 · Part 7: TRT in 2026: Why Prescriptions Are Surging and What the Risks Really Are#

Testosterone replacement therapy is effective. In men with genuinely low testosterone, it raises serum levels reliably, improves body composition measurably, enhances sexual function consistently, and lifts mood and energy within weeks. The clinical evidence for its efficacy isn’t up for debate.

The question isn’t whether TRT works. The question is whether your situation justifies skipping every natural intervention in favor of a commitment that, once started, may be difficult—or impossible—to walk back. And it’s a question worth asking carefully, because TRT prescriptions have surged in recent years—a trend that experts at the Pharmaceutical Journal attribute partly to shifting diagnostic goalposts and aggressive direct-to-consumer marketing, not just a genuine rise in clinical hypogonadism.

What TRT Actually Does#

TRT delivers exogenous testosterone straight into your system—via injection, transdermal gel, patch, or pellet. It bypasses the entire HPG axis. No GnRH from the hypothalamus needed. No LH from the pituitary needed. No signal for the testes to respond to. The hormone arrives from outside, and your blood levels climb accordingly.

That bypass is exactly what makes it effective—and exactly what makes it consequential. When exogenous testosterone floods the system, the HPG axis reads the elevated levels and does what it was designed to do: scale back its own output. GnRH secretion drops. LH and FSH decline. The testes, receiving less stimulation, dial down endogenous production and may shrink over time.

This isn’t a side effect. It’s the intended function of a negative feedback loop encountering a signal it reads as “production is already covered.” The system is working correctly. It’s just working correctly in response to an external input that you’re now responsible for supplying—indefinitely.

The Dependency Question#

TRT doesn’t create addiction. It creates physiological dependency—and the distinction matters.

While you’re on TRT, your endogenous production is suppressed. If you stop, your HPG axis has to restart—a process that can take weeks to months, and in some cases may not fully bounce back, especially after extended use. During recovery, testosterone drops below your pre-TRT baseline because the machinery that was making your testosterone has been sitting idle.

This means starting TRT isn’t a decision to “try something and see how it goes.” It’s a decision to enter a long-term—potentially lifelong—commitment to exogenous hormone management. For some men, that’s absolutely the right call. For others, it’s a call made too early, before simpler interventions got a real shot.

The Real Benefits#

In clinically hypogonadal men, TRT delivers meaningful, well-documented improvements across the board.

Body composition. More lean muscle, less visceral fat, improved waist-to-hip ratio. Consistent across studies, typically visible within the first three to six months.

Sexual function. Better libido, stronger erectile function, higher sexual satisfaction. Most pronounced in men with genuinely low baselines, tending to plateau once levels reach the mid-normal range.

Mood and cognition. Fewer depressive symptoms, more energy and motivation, sharper mental clarity. These psychological wins are among the most valued by men on TRT and show up consistently in quality-of-life assessments.

Bone density. Long-term TRT increases bone mineral density, cutting fracture risk—especially relevant for older hypogonadal men facing elevated osteoporosis risk.

Metabolic markers. Some studies show improved insulin sensitivity and lower inflammatory markers, though these effects are less consistent than the body composition and sexual function gains.

The Real Risks#

TRT isn’t a free lunch, and honest assessment means owning the costs.

Erythrocytosis. TRT reliably ramps up red blood cell production—sometimes too much. Elevated hematocrit thickens the blood and potentially raises clotting risk. Regular CBC monitoring is non-negotiable, and some men need periodic blood donation or dose adjustments to keep hematocrit in a safe zone.

Fertility suppression. Exogenous testosterone suppresses LH and FSH, which are essential for sperm production. Men on TRT frequently see sperm counts drop significantly—sometimes to zero. This usually reverses after stopping, but recovery can be slow and incomplete. Men who want future kids need to have this conversation explicitly before starting, and HCG co-administration may be necessary to preserve fertility.

Cardiovascular uncertainty. TRT’s cardiovascular safety has been debated for over a decade. The TRAVERSE trial (2023) offered reassurance that TRT doesn’t increase major adverse cardiovascular events in men with existing risk factors. But the question isn’t fully settled across all populations, and individual risk assessment remains essential. A recent MSN-published medical review reinforced the nuance: while short-to-medium-term cardiovascular data is generally reassuring, the long-term profile—particularly cancer risk and vascular effects over decades—still lacks the definitive large-scale evidence many clinicians want before prescribing with full confidence.

Mood instability. Injection-based TRT creates cyclical hormone swings—peaks after the shot, troughs before the next one. Those fluctuations can produce mood swings, irritability, and energy dips that some men find disruptive. More frequent lower-dose injections or alternative delivery methods can smooth this out.

Prostate monitoring. The old “testosterone causes prostate cancer” idea has been largely debunked, but PSA monitoring stays standard during TRT. Elevated PSA warrants investigation regardless of TRT status.

The Intervention Gradient#

TRT sits at the top of the minimum effective intervention gradient. Below it, in order of escalating intensity:

Level one: lifestyle optimization. Sleep, exercise, nutrition, stress management, body composition. Lowest risk, broadest benefits, most sustainable long-term impact. These go first and need adequate time—at least three to six months—to show what they can do.

Level two: targeted supplementation. Filling documented micronutrient gaps (zinc, magnesium, vitamin D), adding adaptogens for stress modulation, fixing metabolic factors that suppress endogenous production. Guided by blood work, verified with retesting.

Level three: pharmaceutical support for endogenous production. Clomiphene citrate, enclomiphene, or HCG—compounds that prod the HPG axis to boost its own testosterone output rather than replacing it. These preserve fertility and HPG axis function but carry their own side-effect profiles and require medical oversight.

Level four: TRT. Exogenous replacement. The most effective, the most immediate, and the most consequential in terms of long-term commitment and HPG axis suppression.

The gradient exists because each level deserves a genuine shot—implemented with adequate time and monitoring—before you move up. A man who sleeps five hours a night, eats poorly, never exercises, and hasn’t had blood work done shouldn’t be starting TRT. He should be starting at level one.

The Decision Checklist#

Before initiating TRT, confirm these steps are done:

  • Two or more morning blood tests confirming consistently low testosterone (not a single snapshot)
  • Comprehensive panel including free T, SHBG, LH, FSH, estradiol, prolactin, TSH, and metabolic markers
  • LH/FSH assessment to distinguish primary from secondary hypogonadism
  • Three to six months of documented lifestyle optimization with follow-up labs showing inadequate improvement
  • Evaluation and correction of reversible causes: sleep disorders, obesity, medication effects, chronic stress
  • Informed discussion of fertility implications, monitoring requirements, and the long-term nature of the commitment

If every box is checked and testosterone remains clinically low with persistent symptoms, TRT may be the right next step. If they’re not all checked, you’re making a decision with incomplete information—and incomplete information produces suboptimal decisions.

TRT is a powerful tool. Use it when the situation calls for it. Don’t reach for it before you’ve given your body a genuine chance to solve the problem itself.